Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
Clinical trial NCT00459771 · COMPLETED
Trial details
- NCT number
- NCT00459771
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2013-12-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.